Retrospective analysis of interventional treatment of hepatic metastasis from gastroenteropancreatic neuroendocrine tumors

被引:1
|
作者
Peng Liu [1 ]
Xu Zhu [1 ]
Jie Li [2 ]
Ming Lu [2 ]
Jiahua Leng [3 ]
Ying Li [4 ]
Jiangyuan Yu [5 ]
机构
[1] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Interventional Therapy,Peking University Cancer Hospital & Institute
[2] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Gastroenterological Oncology,Peking University Cancer Hospital & Institute
[3] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Center of Gastrointestinal Surgery Unit Ⅲ,Peking University Cancer Hospital & Institute
[4] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital & Institute
[5] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Nuclear Medicine,Peking University Cancer Hospital & Institute
基金
中国国家自然科学基金;
关键词
Gastroenteropancreatic neuroendocrine tumors; hepatic metastasis; angiography; interventional treatment; retrospective analysis;
D O I
暂无
中图分类号
R735 [消化系肿瘤];
学科分类号
摘要
Objective: To analyze the angiography appearance of liver metastases from gastroenteropancreatic neuroendocrine tumors(GEP-NETs),and evaluate the clinical efficacy and prognostic factors of interventional treatment for hepatic metastases.Methods: Fifty GEP-NETs patients with hepatic metastases were treated from January 2012 to December 2016,and received transarterial embolization(TAE) in the hepatic tumor or hepatic arterial infusion chemotherapy(HAIC).All patients received 179 times of the intervention therapy in total.Results: Blood supplies were identified in the 50 cases with angiography,which showed that 35 cases had abundant vessels,while 15 cases had poor blood supply.Twenty-two cases were found either collateral blood supply,or portal vein invasion or arterial-portal vein fistula.The best curative efficacy was complete remission(CR)in 4 cases,partial remission(PR) in 28 cases and stable disease(SD) in 18 cases during the process of treatment.The angiography(P=0.047) and the frequency of intervention(P=0.037) showed significantly statistical difference with Kaplan-Meier analysis.The Cox analysis showed that more than 3 times of interventional therapy was an independent prognostic factor.Conclusions: Interventional treatment is safe and effective for GEP-NETs,and is beneficial to patients with main hepatic metastases after endocrine therapy.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 50 条
  • [41] Everolimus in the treatment of neuroendocrine tumors of the respiratory and gastroenteropancreatic systems
    Flaum, Nicola
    Valle, Juan W.
    Mansoor, Wasat
    McNamara, Mairead G.
    FUTURE ONCOLOGY, 2016, 12 (22) : 2561 - 2578
  • [42] Radiopeptide therapy: the "Mustang" of treatment for gastroenteropancreatic neuroendocrine tumors
    Gabriel, Michael
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2018, 11 (03): : 81 - 85
  • [43] Management of Advanced Neuroendocrine Tumors With Hepatic Metastasis
    Khasraw, Mustafa
    Gill, Anthony
    Harrington, Tim
    Pavlakis, Nick
    Modlin, Irvin
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (09) : 838 - 847
  • [44] Liver transplantation in the treatmen of unresectable hepatic metastasis from neuroendocrine tumors
    Kim, Joohyun
    Zimmerman, Michael A.
    Hong, Johnny C.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (03) : 601 - 608
  • [45] GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS: SIZE AS AN INDICATOR OF LYMPH NODE AND DISTANT METASTASIS AND SURVIVAL
    Bloom-Feshbach, Kimberly
    Martin, Jacob A.
    Yoon, Jiyoon
    Wisnivesky, Juan
    Kim, Michelle K.
    GASTROENTEROLOGY, 2017, 152 (05) : S669 - S669
  • [46] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [47] NEW MOLECULAR ASPECTS FOR THE DIAGNOSIS AND TREATMENT OF NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS
    WIEDENMANN, B
    AHNERTHILGER, G
    KVOLS, LK
    RIECKEN, EO
    MOLECULAR AND CELL BIOLOGICAL ASPECTS OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE, 1994, 733 : 515 - 525
  • [48] Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Allaw, Mohammed B.
    Switchenko, Jeffrey M.
    Khalil, Lana
    Wu, Christina
    Alese, Olatunji B.
    Akce, Mehmet
    Draper, Amber
    Jones, Aaron T.
    El-Rayes, Bassel
    Shaib, Walid
    ONCOLOGY, 2022, : 131 - 139
  • [49] Non-surgical options in the treatment of gastroenteropancreatic neuroendocrine tumors
    Busse, Franziska Philomena
    Moessner, Joachim
    Stumvoll, Michael
    Kluge, Regine
    Schoppmeyer, Konrad
    CHIRURGISCHE GASTROENTEROLOGIE, 2007, 23 (02): : 158 - 165
  • [50] Recent Progress in the Understanding, Diagnosis, and Treatment of Gastroenteropancreatic Neuroendocrine Tumors
    Turaga, Kiran K.
    Kvols, Larry K.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (02) : 113 - 132